Loncastuximab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Loncastuximab, covering 2025-08-05 to 2025-08-05. Get the full timeline:
Most recent: Clinical Trial Update: Loncastuximab and Roflumilast Added to R-CHOP (Lo-(Rituximab and Roflumilast) RR-CHOP) for Naïve High-Risk Diffuse Large B-cell Lymphoma (DLBCL) [Phase 1]